LINE: Treatment patterns in postmenopausaL women with hormone receptor positive breast cancer - LINE

Study identifier:NIS-ORU-XXX-2011/1

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

LINE: Treatment patterns in postmenopausaL women with hormone receptor positive breast cancer

Medical condition

local advanced or metastatic postmenopausal breast cancer

Phase

N/A

Healthy volunteers

No

Study drug

-

Sex

Female

Actual Enrollment

153

Study type

Observational

Age

N/A

Date

Study Start Date: 01 May 2012
Primary Completion Date: 01 Jan 2015
Study Completion Date: 01 Jan 2015

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Jan 2016 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria